CRVS Competitors & Alternatives
Compare Corvus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
CRVS
Main Stock$15.62
Tradestie Score
56
Market Cap
$540.97M
Analyst Upside
+113.4%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.50
|
$1.42B | - | 54 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$21.11
|
$1.35B | - | 59 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$33.74
|
$1.32B | - | 49 | Compare |
|
MPLT
MPLT
|
$30.31
|
$1.30B | - | 59 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$6.09
|
$1.29B | - | 60 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$33.33
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.97
|
$1.29B | - | 55 | Compare |
|
ZYME
Zymeworks Inc.
|
$27.94
|
$1.28B | - | 64 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.56
|
$1.27B | - | 48 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$39.59
|
$1.26B | - | 51 | Compare |
More CRVS Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry